Stephens Inc Ionis Pharmaceuticals Inc Transaction History

Stephens Inc

$6.2 Billion
Q1 2024

A detailed history of Stephens Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Stephens Inc holds 7,853 shares of IONS stock, worth $370,975. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,853

Previous 7,955 1.28%

Holding current value

$370,975

Previous $402,000 15.42%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $4,287 - $5,462	-102 Reduced 1.28%	7,853 $340,000
Q4 2023 Feb 13, 2024	BUY	$43.39 - $51.63 $20,393 - $24,266	470 Added 6.28%	7,955 $402,000
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $808 - $989	-21 Reduced 0.28%	7,485 $339,000
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $5,695 - $7,106	164 Added 2.23%	7,506 $307,000
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $11,383 - $13,966	339 Added 4.84%	7,342 $262,000

Q4 2022 Jan 25, 2023	SELL	$37.12 - $46.52 $78,768 - $98,715	-2,122 Reduced 23.25%	7,003 $265,000
Q3 2022 Nov 02, 2022	SELL	$36.54 - $48.66 $92,044 - $122,574	-2,519 Reduced 21.63%	9,125 $404,000
Q2 2022 Aug 03, 2022	SELL	$31.71 - $43.0 $28,792 - $39,044	-908 Reduced 7.23%	11,644 $431,000
Q1 2022 May 04, 2022	SELL	$29.88 - $37.04 $153,852 - $190,718	-5,149 Reduced 29.09%	12,552 $465,000
Q4 2021 Mar 07, 2022	SELL	$25.61 - $35.1 $88,098 - $120,744	-3,440 Reduced 16.27%	17,701 $539,000
Q3 2021 Oct 27, 2021	SELL	$33.54 - $40.55 $150,829 - $182,353	-4,497 Reduced 17.54%	21,141 $709,000
Q2 2021 Aug 12, 2021	BUY	$34.54 - $47.25 $16,648 - $22,774	482 Added 1.92%	25,638 $1.02 Million
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $40,512 - $60,782	-953 Reduced 3.65%	25,156 $1.13 Million
Q4 2020 Feb 10, 2021	BUY	$45.3 - $60.27 $213,408 - $283,931	4,711 Added 22.02%	26,109 $1.48 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $10,913 - $14,478	-230 Reduced 1.06%	21,398 $1.02 Million
Q2 2020 Aug 24, 2020	SELL	$46.85 - $61.05 $31,998 - $41,697	-683 Reduced 3.06%	21,628 $1.28 Million
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $30,284 - $46,155	-728 Reduced 3.16%	22,311 $1.06 Million
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $63,004 - $76,365	1,170 Added 5.35%	23,039 $1.39 Million
Q3 2019 Oct 18, 2019	SELL	$59.06 - $72.15 $31,006 - $37,878	-525 Reduced 2.34%	21,869 $1.31 Million
Q2 2019 Aug 01, 2019	BUY	$62.09 - $86.14 $52,528 - $72,874	846 Added 3.93%	22,394 $1.44 Million
Q1 2019 May 03, 2019	SELL	$52.92 - $81.17 $42,494 - $65,179	-803 Reduced 3.59%	21,548 $1.75 Million
Q4 2018 Feb 11, 2019	SELL	$43.37 - $59.54 $19,386 - $26,614	-447 Reduced 1.96%	22,351 $1.21 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $977,578 - $1.22 Million	22,798 New	22,798 $1.18 Million

Others Institutions Holding IONS

# of Institutions

398

Shares Held

122M

Call Options Held

854K

Put Options Held

464K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.71B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account